Scandinavian ChemoTech (Sweden) Probability of Future Stock Price Finishing Over 1.74
| CMOTEC-B | SEK 1.74 0.04 2.35% |
Scandinavian |
Scandinavian ChemoTech Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Scandinavian ChemoTech for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Scandinavian ChemoTech can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Scandinavian ChemoTech generated a negative expected return over the last 90 days | |
| Scandinavian ChemoTech may become a speculative penny stock | |
| Scandinavian ChemoTech has high historical volatility and very poor performance | |
| Scandinavian ChemoTech has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the revenue of 49 K. Net Loss for the year was (17.74 M) with profit before overhead, payroll, taxes, and interest of 2.86 M. | |
| Scandinavian ChemoTech AB has accumulated about 5.62 M in cash with (19.18 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.65. | |
| Roughly 26.0% of the company shares are held by company insiders |
Scandinavian ChemoTech Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Scandinavian Stock often depends not only on the future outlook of the current and potential Scandinavian ChemoTech's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Scandinavian ChemoTech's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 9.6 M | |
| Cash And Short Term Investments | 8.7 M |
Scandinavian ChemoTech Technical Analysis
Scandinavian ChemoTech's future price can be derived by breaking down and analyzing its technical indicators over time. Scandinavian Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Scandinavian ChemoTech AB. In general, you should focus on analyzing Scandinavian Stock price patterns and their correlations with different microeconomic environments and drivers.
Scandinavian ChemoTech Predictive Forecast Models
Scandinavian ChemoTech's time-series forecasting models is one of many Scandinavian ChemoTech's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Scandinavian ChemoTech's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Scandinavian ChemoTech
Checking the ongoing alerts about Scandinavian ChemoTech for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Scandinavian ChemoTech help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Scandinavian ChemoTech generated a negative expected return over the last 90 days | |
| Scandinavian ChemoTech may become a speculative penny stock | |
| Scandinavian ChemoTech has high historical volatility and very poor performance | |
| Scandinavian ChemoTech has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the revenue of 49 K. Net Loss for the year was (17.74 M) with profit before overhead, payroll, taxes, and interest of 2.86 M. | |
| Scandinavian ChemoTech AB has accumulated about 5.62 M in cash with (19.18 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.65. | |
| Roughly 26.0% of the company shares are held by company insiders |
Other Information on Investing in Scandinavian Stock
Scandinavian ChemoTech financial ratios help investors to determine whether Scandinavian Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Scandinavian with respect to the benefits of owning Scandinavian ChemoTech security.